The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Cebranopadol reduced pain intensity in patients following abdominoplasty surgery in the ALLEVIATE-1 clinical trial.

Mood lability due to oral contraceptive use was associated with a higher likelihood of oral contraceptive discontinuation in endometriosis.

HealthDay News — In an American Academy of Pediatrics clinical report published online Jan. 21 in Pediatrics, guidance is presented for the diagnosis of pediatric fractures and assessment of suspected ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

HealthDay News — For the first time, bird flu has been detected in a commercial poultry flock in Georgia. The case — ...

US high school students do not engage in adequate levels of healthy dietary, physical activity, and sleep behaviors.

The Advisory Committee on Immunization Practices approved immunization schedules for children and adolescents and for adults for 2025. HealthDay News — The Advisory Committee on Immunization ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Private equity acquisition of US hospitals was associated with a significant worsening of patient-reported care experiences.

For individuals reporting cannabis use, the odds of opioid misuse are reduced among individuals in states with medical ...

For early postmenopausal women, zoledronate administered at baseline and 5 years is effective for preventing morphometric ...